NICE recommends Pfizer's migraine drug for use in the UK, with some restrictions
The UK’s National Institute for Health and Care Excellence (NICE) is recommending Pfizer’s oral migraine drug rimegepant, known commercially in the US as Nurtec and …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.